3-carbonylamino-5-cyclopentyl-1 Fi-pyrazole compounds having inhibitory activity on CDK2

This invention relates to compounds of Formula (I), and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein R

Saved in:
Bibliographic Details
Main Authors FREEMAN-COOK, Kevin Daniel, SUTTON, Scott Channing, NAGATA, Asako, BEHENNA, Douglas Carl, NINKOVIC, Sacha, HOFFMAN, Robert Louis
Format Patent
LanguageEnglish
Published 17.11.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract This invention relates to compounds of Formula (I), and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein R
AbstractList This invention relates to compounds of Formula (I), and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein R
Author SUTTON, Scott Channing
HOFFMAN, Robert Louis
NAGATA, Asako
FREEMAN-COOK, Kevin Daniel
BEHENNA, Douglas Carl
NINKOVIC, Sacha
Author_xml – fullname: FREEMAN-COOK, Kevin Daniel
– fullname: SUTTON, Scott Channing
– fullname: NAGATA, Asako
– fullname: BEHENNA, Douglas Carl
– fullname: NINKOVIC, Sacha
– fullname: HOFFMAN, Robert Louis
BookMark eNqNyr8KwjAQgPEMOvjvHTK4BmxLdbbVIrgquJVrPO1BehfaWIhPr4MPIN_wW765mrAwztQtMxb6Rjg66IjF5MZG68Qjh-hMoisyPvbwFofaSuflxfdBtzASPzVxSw0F6aMGG2ikELWwLg_ndKmmD3ADrn4u1Lo6XsqTQS81Dh4sMoZ6f00335Jst02KIs3-3D4EzDzO
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2020213761BB2
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2020213761BB23
IEDL.DBID EVB
IngestDate Fri Jul 19 12:49:57 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2020213761BB23
Notes Application Number: AU20200213761
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221117&DB=EPODOC&CC=AU&NR=2020213761B2
ParticipantIDs epo_espacenet_AU2020213761BB2
PublicationCentury 2000
PublicationDate 20221117
PublicationDateYYYYMMDD 2022-11-17
PublicationDate_xml – month: 11
  year: 2022
  text: 20221117
  day: 17
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies PFIZER INC
RelatedCompanies_xml – name: PFIZER INC
Score 3.4393833
Snippet This invention relates to compounds of Formula (I), and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 3-carbonylamino-5-cyclopentyl-1 Fi-pyrazole compounds having inhibitory activity on CDK2
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221117&DB=EPODOC&locale=&CC=AU&NR=2020213761B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1NS8NAEB1KFfWmVfGrsoeS22Lz0cQeipikoSi2RVrpreymWw3ETWkiUn-9M6HVnvQWsrAkA28nk3lvHkCj2bbmrmp7nJwsuGM7gkvPkxxzkVCuK6yZKgmyfbc3dh4mrUkF0o0WppwT-lkOR0RExYj3ojyvF78_scKSW5nfyARvZXfRqBMa6-rYwnLG9IzQ73SHg3AQGEGAlaTRf6Y1zGaIJtPHA3sHP6Q9IoB1X3zSpSy2k0p0CLtD3E8XR1BRugb7wcZ7rQZ7T-uWN16u0Zcfw8TmsVhK4pKL90RnvMXjVZySAVaxSrnJooQvVkvxlaWKEVecLJNyRjp8_coS_ZbIhHrqjMQM5BnBMs2C8NE6gUbUHQU9jo84_YnI9H689T6-ZZ9CVWdanQGjrgqiWM1VrBzHnonbmSk91aRRS45s2edQ_3Ori3_WL-GAwkxqPNO7gmqx_FB1TMuFvC6j-Q1Gy5BC
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LT8JAEJ4QNOJNUeML3QPpbSN90MKBGNtCUJ4xYLiRblm0Sd0SqDH4651pQDnpbbObbLqTfDudnfnmAyhX6sbclnWHk5IFt0wr4MJxBEdfFEjbDoyZzApk-3Z7bD1NqpMcxFsuTNYn9DNrjoiIChHvaXZfL34fsfystnJ1JyKcSu5bo4avbaJjA8MZ3dF8t9EcDvyBp3keRpJa_5nW0JshmnQXL-w9_MmuUaf95otLvJTFrlNpHcH-EPdT6THkpCpCwdtqrxXhoLdJeeNwg77VCUxMHgZLQbXkwXukEl7l4TqMSQArXcdcZ62IL9bL4CuJJaNacZJMWjHi4atXFqm3SESUU2dEZiDNCJYo5vkd4xTKrebIa3P8xOmPRaYP453zuIZ5BnmVKHkOjLIqiGI5l6G0LHMW1Ga6cGSFWi1ZompeQOnPrS7_Wb-FQnvU6067j_3OFRySyYmZpzvXkE-XH7KELjoVN5llvwEzdpMy
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=3-carbonylamino-5-cyclopentyl-1+Fi-pyrazole+compounds+having+inhibitory+activity+on+CDK2&rft.inventor=FREEMAN-COOK%2C+Kevin+Daniel&rft.inventor=SUTTON%2C+Scott+Channing&rft.inventor=NAGATA%2C+Asako&rft.inventor=BEHENNA%2C+Douglas+Carl&rft.inventor=NINKOVIC%2C+Sacha&rft.inventor=HOFFMAN%2C+Robert+Louis&rft.date=2022-11-17&rft.externalDBID=B2&rft.externalDocID=AU2020213761BB2